Table: Taiko Pharmaceutical -2021 parent results

Taiko Pharmaceutical

18/02/2022 06:30

Feb 18 (Reuters)- 
          Taiko Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                    Year ended      Year ended       Year to     NEXT     
                 Dec 31, 2021    Dec 31, 2020   Dec 31, 2022     YEAR     
                    LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS          RESULTS       FORECAST    H1 FORECAST 
  Sales             10.60            17.09                                
  Operating       loss 5.02           5.62                                
  Recurring       loss 5.86           5.47                                
  Net             loss 9.27           3.87                                
  EPS          loss 213.03 yen     89.57 yen                              
  EPS Diluted                      89.21 yen                              
  Ann Div            NIL           25.00 yen                              
  -Q2 Div            NIL           7.00 yen                               
  -Q4 Div            NIL           18.00 yen                              
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T